uses machine-learning techniques to analyze genomic data in combination with various sources of scientific literature to characterize polygenetic biomarkers and inform the development of novel diagnostics and therapies. The company uses open-source data to generate its internal biomarker portfolio as well as the data of pharmaceutical and biotechnology companies to help those clients direct their research efforts.